Merck (MRK) is reportedly planning to double the production of molnupiravir, an antiviral COVID pill, next year. The Financial Times reported the drugmaker has secured deals to provide COVID ...
Pfizer Inc (NYSE: PFE) made a promise to outdo cancer, joining its Covid vaccine-peer, Moderna Inc (NASDAQ: MRNA) in turning ...
An FDA advisory committee voted by 13 to 10 to recommend emergency-use authorisation for Merck & Co and Ridgeback's oral antiviral molnupiravir for mild-to-moderate COVID-19, saying it would be ...
The first-ever COVID-19 pill could be available before the end of the year. This week, Merck and Ridgeback Biotherapeutics asked the Food and Drug Administration (FDA) to authorize their antiviral ...
Merck & Co is on the brink of plugging a gap in the coronavirus treatment armamentarium after its oral drug molnupiravir cut deaths and hospitalisations in mild or moderate COVID-19 in a phase 3 ...
Merck and Ridgeback Biotherapeutics withdrew their COVID-19 pill application in the European Union due to insufficient data for not backing the drug. Additionally, a recent study featured in the ...
Merck MRK announced that the FDA had granted approval to V116 ... the co-administration of its Prevnar-20 vaccine with its COVID-19 vaccine. GSK GSK has a 24-valent PCV in its pipeline, which ...
Merck (NYSE: MRK) stock has been a longtime winner for investors, returning 72% in the past five years. A major factor in ...
Its vaccine is under FDA review. A panel of vaccine ... Positive clinical trial results for Merck & Co's experimental antiviral COVID-19 pill reverberated through the health care sector on Friday ...
Summit Therapeutics' ivonescimab poised for FDA approval, with the potential to disrupt the oncology market. Read more on ...
Wednesday, the FDA approved Merck & Co Inc’s (NYSE:MRK) Keytruda (pembrolizumab) in combination with pemetrexed and platinum chemotherapy for the first-line treatment of adult patients with ...
Positive clinical trial results for Merck & Co's experimental antiviral COVID-19 pill reverberated ... Reports that Food and Drug Administration officials plan to step down over the White House ...